Sign In
Buy DBVT
$15.82
+0.0900 (+0.572%)
At Close: Jul 02, 2026
DBV Technologies To Present at the Goldman Sachs 41st Annual Global Healthcare Conference
08:30pm, Tuesday, 02'nd Jun 2020
Montrouge, France, June 2, 2020 DBV Technologies To Present at the Goldman Sachs 41st Annual Global Healthcare Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345.
DBV Technologies To Present at the Goldman Sachs 4–st Annual Global Healthcare Conference
12:00am, Tuesday, 02'nd Jun 202020 Healthcare Stocks Moving In Thursday's Pre-Market Session
12:00am, Thursday, 21'st May 2020Perceptive Advisors Llc Buys Iovance Biotherapeutics Inc, Zymeworks Inc, Regeneron ...
12:00am, Monday, 18'th May 2020Perceptive Advisors Llc Buys Iovance Biotherapeutics Inc, Zymeworks Inc, Regeneron ...
12:00am, Friday, 15'th May 2020Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2020
08:01pm, Tuesday, 12'th May 2020
Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2020 (Article 223-16 of the General Regulations of the.
20 Healthcare Stocks Moving In Tuesday's Pre-Market Session
11:33am, Tuesday, 12'th May 2020Information regarding the total number of voting rights and total number of shares of the ...
12:00am, Tuesday, 12'th May 202017 Healthcare Stocks Moving In Friday's Pre-Market Session
11:50am, Friday, 08'th May 2020DBV TECHNOLOGIE/S (NASDAQ:DBVT) Given Consensus Rating of "Buy" by Brokerages
06:20am, Friday, 01'st May 2020
Shares of DBV TECHNOLOGIE/S (NASDAQ:DBVT) have received a consensus recommendation of “Buy” from the thirteen analysts that are presently covering the stock, Marketbeat.com reports. Four investmen
